Tom Shimabukuro: Last News

Heart inflammation cases higher in 16-24 age group after 2nd mRNA COVID-19 shot: CDC

COVID-19 vaccines in 16 to 24 year olds, the U.S. Centers for Disease Control and Prevention said on Thursday.More than half of the myocarditis or pericarditis cases reported to the U.S.

Vaccine Adverse Event Reporting System after patients had received either the Pfizer/BioNTech or Moderna vaccines were in people between the ages of 12 and 24, the CDC said. Those age groups accounted for less that 9% of the doses administered.The limited data shows that most of the patients – at least 81 percent of them – had a full recovery from their symptoms, the CDC said in a presentation prepared for an advisory committee to the U.S.

Food and Drug Administration that is meeting on Thursday.“We clearly have an imbalance there,” Dr. Tom Shimabukuro,

. covid-19 reports vaccine

Tom Shimabukuro

Related News